VC
CBAY

Vivo Capital’s Cymabay Therapeutics CBAY Stock Holding History

Vivo Capital’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-585,394
Closed -$3.36M – 69
2020
Q4 		$3.36M Sell
585,394
-1,503,962
-72% -$11.4M 0.15% 52
2020
Q3 		$15.1M Hold
2,089,356
– – 0.87% 33
2020
Q2 		$7.29M Buy
2,089,356
+1,011,889
+94% +$2.92M 0.52% 39
2020
Q1 		$1.59M Buy
+1,077,467
New +$1.81M 0.14% 49
2019
Q3 		– Sell
-2,154,934
Closed -$15.4M – 33
2019
Q2 		$15.4M Buy
2,154,934
+98,934
+5% +$1.12M 1.45% 20
2019
Q1 		$27.3M Buy
2,056,000
+1,150,000
+127% +$12.2M 2.72% 12
2018
Q4 		$7.13M Hold
906,000
– – 0.91% 29
2018
Q3 		$10M Hold
906,000
– – 1.01% 25
2018
Q2 		$12.2M Buy
906,000
+106,000
+13% +$1.33M 1.57% 18
2018
Q1 		$10.4M Buy
+800,000
New +$9.94M 1.47% 17

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return